Preclinical Development of AT1412, a Patient Derived CD9 Antibody That Does Not Induce Thrombosis for Treatment of B ALL

Schotte, R; Villaudy, J; De Jong, G; Neviani, V; Pos, W; Levie, SE; Go, DM; Yasuda, E; Frankin, E; Cercel, M; van Hal-van Veen, SE; van de Berg, D; Szabo, A; Fatmawati, C; Kedde, M; Claassen, Y; Horbach, S; Rijneveld, AW; Gros, P; Spits, H; Hazenberg, MD; van Eenennaam, H

BLOOD, 2020; 136 ():